US 6291469
Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation
expired A61KA61K31/423A61K31/437
Quick answer
US patent 6291469 (Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation) held by COR Therapeutics, Inc. expires Mon Sep 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- COR Therapeutics, Inc.
- Grant date
- Tue Sep 18 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 41
- CPC classes
- A61K, A61K31/423, A61K31/437, A61P, A61P7/00